Circulating memory B-cell receptor repertoire analysis identifies novel candidate antibodies against metastatic melanoma in immunotherapy-responsive patients

Although our study is based on a limited number of individuals, our observations indicate that it may be possible to further investigate the human response to immunotherapy for the identification of rare mature B clonotypes targeting plasma membrane antigens on tumor cells. These preliminary findings could contribute to the future development of fully human-compatible immunotherapies, pending additional validation and <i>in vivo</i> studies.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-10-09
DOI
https://doi.org/10.3389/fimmu.2025.1636722
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Circulating memory B-cell receptor repertoire analysis identifies novel candidate antibodies against metastatic melanoma in immunotherapy-responsive patients

Valentina Ancarani, Francesco Limarzi, Matteo Zurlo, Federica Marocchi et al.
Frontiers in Immunology
Cancer Immunotherapy and Biomarkers
article

Circulating memory B-cell receptor repertoire analysis identifies novel candidate antibodies against metastatic melanoma in immunotherapy-responsive patients

Valentina Ancarani, Francesco Limarzi, Matteo Zurlo, Federica Marocchi, Massimiliano Mazza, Anna De Lucia, Anna Gaimari, Davide Angeli, Massimo Guidoboni, Luigi Pasini, Luisa Lanfrancone, Roberta Maltoni, Sara Bravaccini, Patricia Borges de Souza, Fabio Nicolini, Laura Ridolfi, Maria Maddalena Tumedei, C Magnoni, Claudio Cerchione, Lucia Mazzotti, Sara Capobianco, Luca Gazzola, Miriana Ghirelli
article en

Abstract

Although our study is based on a limited number of individuals, our observations indicate that it may be possible to further investigate the human response to immunotherapy for the identification of rare mature B clonotypes targeting plasma membrane antigens on tumor cells. These preliminary findings could contribute to the future development of fully human-compatible immunotherapies, pending additional validation and <i>in vivo</i> studies.

Frontiers in ImmunologyVol. 16
University of Ferrara (IT), Università degli Studi di Enna Kore (IT), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT), Azienda Unità Sanitaria Locale Della Romagna (IT), Ospedale G.B. Morgagni - L.Pierantoni (IT), European Institute of Oncology (IT), University of Bologna (IT)
Ministero della Salute, Fondazione Umberto Veronesi
Openalex Percentile: Top 61%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.